Critical Path Institute (C-Path) has named Daniel M. Jorgensen, M.D., MPH, MBA, as its Chief Executive Officer as of October 1st. Jorgensen is an experienced leader in drug development, healthcare and business, and will continue C-Path’s collaboration with global stakeholders, including patient groups, academic institutions, the pharmaceutical industry and regulatory agencies, to set a vision for C-Path’s next phase of growth and innovation.    “Dr. Jorgensen has long been a ...